Anxiety Disorders Terminated Phase 2 Trials for Buspirone (DB00490)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01496612Buspirone Therapy for Localized EpilepsyTreatment